National Planning Corporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,586
Closed -$820K 361
2017
Q3
$820K Buy
9,586
+108
+1% +$8.86K 0.07% 260
2017
Q2
$784K Buy
9,478
+737
+8% +$60.1K 0.06% 300
2017
Q1
$753K Sell
8,741
-1,357
-13% -$109K 0.06% 290
2016
Q4
$781K Sell
10,098
-233
-2% -$17.4K 0.06% 278
2016
Q3
$763K Sell
10,331
-1,937
-16% -$155K 0.06% 276
2016
Q2
$1.02M Sell
12,268
-1,090
-8% -$82.1K 0.08% 235
2016
Q1
$997K Sell
13,358
-2,110
-14% -$160K 0.09% 229
2015
Q4
$1.15M Buy
15,468
+2,847
+23% +$236K 0.09% 229
2015
Q3
$1.02M Sell
12,621
-8,596
-41% -$726K 0.09% 209
2015
Q2
$1.77M Sell
21,217
-830
-4% -$63.2K 0.16% 137
2015
Q1
$1.58M Sell
22,047
-1,301
-6% -$92.6K 0.14% 145
2014
Q4
$1.62M Buy
23,348
+1,312
+6% +$88.6K 0.11% 169
2014
Q3
$1.45M Sell
22,036
-2,859
-11% -$181K 0.11% 183
2014
Q2
$1.55M Buy
24,895
+3,474
+16% +$207K 0.12% 175
2014
Q1
$1.27M Buy
21,421
+248
+1% +$13.8K 0.11% 188
2013
Q4
$1.08M Buy
21,173
+2,903
+16% +$145K 0.1% 218
2013
Q3
$926K Buy
18,270
+1,732
+10% +$90.7K 0.09% 231
2013
Q2
$808K Buy
+16,538
New +$900K 0.1% 210

Other funds holding LLY

National Planning Corporation's LLY Position: Q4 2017 in Review

National Planning Corporation sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 9,586 shares — an estimated $820K sold.

National Planning Corporation first reported a position in LLY in Q2 2013 and held it in 18 quarters. The position peaked at $1.77M in Q2 2015. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • National Planning Corporation reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 9,586 Eli Lilly shares in Q4 2017, an estimated $820K.
  • National Planning Corporation first reported a position in Eli Lilly in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Eli Lilly position peaked at $1.77M in Q2 2015.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.